Reactive Oxygen Species Reduction is a Key Underlying Mechanism of Drug Resistance in Cancer Chemotherapy
sensitive cancer cells. Anticancer drugs induce master regulatory genes and these genes act on NFE2L2-KEAP1 antioxidant system to reduce the ROS level in cancer cells. This review focused

